HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation.

AbstractAIM:
To evaluate the technical feasibility and treatment results of ultrasound (US)-guided percutaneous radiofrequency ablation (RFA) combined with ethanol ablation (EA) for hepatocellular carcinoma (HCC) in the caudate lobe.
MATERIALS AND METHODS:
The institutional review board approved this retrospective study and the requirement for informed consent was waived. From October 2009 to June 2016, there were 49 patients with HCC in the caudate lobe underwent ablation. Among them, 14 patients (12 men and two women, mean age: 49.9±14.9 years) with 16 caudate lobe HCCs (mean size: 3±1.1 cm) who underwent US-guided RFA-EA were identified. These patients were compared with patients who underwent RFA alone (n=17) and EA alone (n=18).
RESULTS:
HCCs in the RFA-EA group were larger than those in the EA-alone group (3±1.1 versus 2.1±0.7 cm, p=0.028). In the RFA-EA group, all the patients achieved treatment success (14/14) and entered follow-up. After a follow-up period of 17.1±10.6 months (range, 5-36 months), local tumour progression (LTP) was detected in four tumours. The 1- and 2-year LTP rates after RFA-EA were 18.8% and 27.8%, respectively. The 1- and 2-year disease-free survival (DFS) rates were 35.7% and 13.4%. Six patients died, with the 1-, 2-, and 3-year overall survival (OS) rates of 85.1%, 63.1%, and 21%, respectively. There were no significant differences in the LTP, DFS, and OS rates between the RFA-EA group and RFA-alone or EA groups (p=0.363-0.733).
CONCLUSION:
US-guided percutaneous RFA-EA appears to be a feasible and effective treatment for HCC in the caudate lobe.
AuthorsB Liu, J Long, W Wang, G Huang, C Jiang, X Zhang, M Liu, P Liang, J Yu, X Xie, M Kuang
JournalClinical radiology (Clin Radiol) Vol. 73 Issue 7 Pg. 647-656 (07 2018) ISSN: 1365-229X [Electronic] England
PMID29627066 (Publication Type: Journal Article)
CopyrightCopyright © 2018. Published by Elsevier Ltd.
Chemical References
  • Solvents
  • Ethanol
Topics
  • Adolescent
  • Adult
  • Aged
  • Carcinoma, Hepatocellular (diagnostic imaging, therapy)
  • Chemoembolization, Therapeutic (methods)
  • Combined Modality Therapy
  • Ethanol (administration & dosage)
  • Feasibility Studies
  • Female
  • Humans
  • Liver (diagnostic imaging, surgery)
  • Liver Neoplasms (diagnostic imaging, therapy)
  • Male
  • Middle Aged
  • Radiofrequency Ablation (methods)
  • Retrospective Studies
  • Solvents (administration & dosage)
  • Survival Rate
  • Treatment Outcome
  • Ultrasonography, Interventional (methods)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: